+1 (502) 904-2126   One Westbrook Corporate Center, Suite 300, Westchester, IL 60154, USA   Site Map
ISSN: 2574 -1241

Impact Factor : 0.548

  Submit Manuscript

Short CommunicationOpen Access

Acute Lymphocytic Leukemia New Prognosis Factors

Volume 6 - Issue 2

Dra Mirta D’ambra*

  • Author Information Open or Close
    • Chairman WAMS, Hospital Argerich, Ministery Health UBA, Buenos Aires Argentina

    *Corresponding author: Dra Mirta D’ambra, Chairman WAMS, Hospital Argerich, Ministery Health UBA, Buenos Aires Argentina, Argentina

Received: June 25, 2018;   Published: July 03, 2018

DOI: 10.26717/BJSTR.2018.06.001329

Full Text PDF

To view the Full Article   Peer-reviewed Article PDF


It is the most common adult leukemia in the western world. Its complexity has increased as a result of the advent of new biological agents, the identification of molecular predictive markers and the introduction of more sensitive and sophisticated techniques evaluate minimal residual disease. The western world, CLL accounts for almost 25% of all leukemias and 1.3% of all cancers. Its incidence is substantially lower among Asian people and higher among Ashkenazi Jews. It is estimated that its incidence will continue its upward trend. It affects mainly elderly people, (more than 70% are> 65 years, the median age at diagnosis is 72 years). Men and white people are more frequently affected than women and other races.

Short Communication| Introduction| Materials and Methods| Results| Discussion| Conclusion| Acknowledgement|